Eiger BioPharmaceuticals, Inc.
EIGR
EIGR: Eiger BioPharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of drugs for serious, rare, and ultra-rare diseases with high unmet medical needs and no approved therapies. Its program lonafarnib, a prenylation inhibitor, boosted with ritonavir, for the treatment of Hepatitis Delta Virus (HDV) infection, is in Phase 3 clinical development. Its product candidate pipeline includes Lonafarnib (LNF) in HDV, Peginterferon Lambda (lambda) in HDV, LNF in Progeria, and Progeroid Laminopathies (PL), Avexitide in Post-Bariatric Hypoglycemia (PBH), and Avexitide in Congenital Hyperinsulinism (CHI), all advancing toward Phase 3.
moreShow EIGR Financials
Recent trades of EIGR by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by EIGR's directors and management
Government lobbying spending instances
-
$60,000 Jul 20, 2021 Issue: Health Issues
-
$60,000 Apr 20, 2021 Issue: Health Issues
-
$40,000 Jan 21, 2021 Issue: Health Issues
New patents grants
-
Patent Title: Methods of using buffered formulations of exendin (9-39) Aug. 29, 2023
-
Patent Title: Methods for the treatment of non-alcoholic steatohepatitis Feb. 07, 2023
-
Patent Title: Methods of treating hepatitis delta virus infection Dec. 06, 2022
-
Patent Title: Treatment of hepatitis delta virus infection Apr. 26, 2022
-
Patent Title: Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives Sep. 14, 2021
-
Patent Title: Buffered formulations of exendin (9-39) Jun. 01, 2021
-
Patent Title: Treatment of hepatitis delta virus infection with interferon lambda Mar. 23, 2021
-
Patent Title: Treatment of hepatitis delta virus infection Nov. 10, 2020
-
Patent Title: Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives May. 19, 2020
-
Patent Title: Methods and pharmaceutical compositions for the treatment of non-alcoholic steatohepatitis Mar. 17, 2020
-
Patent Title: Treatment of hepatitis delta virus infection Sep. 18, 2018
Federal grants, loans, and purchases
Followers on EIGR's company Twitter account
Number of mentions of EIGR in WallStreetBets Daily Discussion
Recent insights relating to EIGR
Recent picks made for EIGR stock on CNBC
ETFs with the largest estimated holdings in EIGR
Flights by private jets registered to EIGR